Drugs for Syncope (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 109)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Β-propranolol
|
|
2 |
|
Midodrine |
Approved |
Phase 4 |
|
133163-28-7, 42794-76-3 |
4195 |
Synonyms:
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-2-Amino-N-(b-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-2-Amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamide
(±)-2-amino-N-(β-hydroxy-2,5-dimethoxyphenethyl)acetamide
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-b-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-β-hydroxyphenethyl)acetamide
A-4020 LINZ
Amatine
Cahill may roberts brand OF midodrine monohydrochloride
Christiaens brand OF midodrine monohydrochloride
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DL-N1-(b-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DL-N1-(Β-hydroxy-2,5-dimethoxyphenethyl)glycinamid
|
Gutron
Midodrin
Midodrina
Midodrine
Midodrine HCL
Midodrine hydrochloride
Midodrine monohydrochloride
Midodrinum
Midon
Monohydrochloride, midodrine
Nycomed brand OF midodrine monohydrochloride
ProAmatine
Shire brand OF midodrine monohydrochloride
ST 1085
ST-1085
|
|
3 |
|
Metoprolol |
Approved, Investigational |
Phase 4 |
|
37350-58-6, 51384-51-1 |
4171 |
Synonyms:
(+/-)-metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
Beatrolol
Beloc
Beloc duriles
Beloc-duriles
BelocDuriles
Betaloc
Betaloc astra
Betaloc-astra
BetalocAstra
Betalok
CGP-2175
CGP-2175C
CGP-2175C|GP-2175E|H-93/26|Lopressor®|Toprol®
CR-XL, Metoprolol
DL-Metoprolol
GP-2175E
H-93/26
Lopresor
Lopresoretic
LOPRESSIDONE
Lopressor
Lopressor HCT
|
Meijoprolol
Metohexal
METOPROLOL
Metoprolol CR XL
Metoprolol CR-XL
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metroprolol
Preblok
Prelis
Presolol
Seloken
Selopral
Selo-Zok
Seroken
Spesicor
Spesikor
Succinate, metoprolol
Tartrate, metoprolol
Toprol
Toprol XL
ToprolXL
Toprol-XL
|
|
4 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
5 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
6 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
7 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
8 |
|
Vasoconstrictor Agents |
|
Phase 4 |
|
|
|
9 |
|
Sympathomimetics |
|
Phase 4 |
|
|
|
10 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
11 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
12 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
13 |
|
Adrenergic beta-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
14 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
15 |
|
Sympatholytics |
|
Phase 4 |
|
|
|
16 |
|
Levodopa |
Approved |
Phase 3 |
|
59-92-7, 63-84-3 |
6047 |
Synonyms:
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(−)-3-(3,4-DIHYDROXYPHENYL)-L-ALANINE
(-)-Dopa
(−)-DOPA
(+-)-3-(3,4-Dihydroxyphenyl)alanine
(+-)-Dopa
(+/-) 3-(3,4-dihydroxyphenyl)alanine
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
(R,S)-Dopa
2-amino-3-(3,4-Dihydroxyphenyl)propanoate
2-amino-3-(3,4-Dihydroxyphenyl)propanoic acid
3 Hydroxy DL tyrosine
3 Hydroxy L tyrosine
3-(3,4-Dihydroxyphenyl)-DL-alanine
3-(3,4-Dihydroxyphenyl)-L-alanine
3,4 Dihydroxyphenylalanine
3,4-Dihydroxy-DL-phenylalanine
3,4-Dihydroxy-L-phenylalanine
3,4-dihydroxy-L-phenylalanine|Inbrija® (levodopa inhalation powder)|L-DOPA|Sinemet®
3,4-Dihydroxyphenylalanine
3',4'-Dihydroxyphenylalanine
3,4-Dihydroxyphenyl-L-alanine
3-Hydroxy-DL-tyrosine
3-Hydroxy-L-tyrosine
3-Hydroxytyrosine
a-amino-3,4-Dihydroxy-benzenepropanoate
a-amino-3,4-Dihydroxy-benzenepropanoic acid
alpha-amino-3,4-Dihydroxy-benzenepropanoate
alpha-amino-3,4-Dihydroxy-benzenepropanoic acid
alpha-amino-Hydrocaffeic acid
b-(3,4-Dihydroxyphenyl)-a-alanine
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
b-(3,4-Dihydroxyphenyl)-DL-a-alanine
b-(3,4-Dihydroxyphenyl)-L-alanine
Bendopa
beta Hydroxytyrosine
beta-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-DL-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
beta-Hydroxytyrosine
BROCADOPA
Cidandopa
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
Dihydroxyphenylalanine hydrochloride, (2:1)
DL-3,4-Dihydroxyphenylalanine
DL-3',4'-Dihydroxyphenylalanine
DL-3,4-Dopa
DL-3-Hydroxytyrosine
DL-4,5-Dihydroxyphenylalanine
DL-b-(3,4-Dihydroxyphenyl)-a-alanine
DL-b-(3,4-Dihydroxyphenyl)alanine
DL-beta-(3,4-Dihydroxyphenyl)alanine
DL-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
DL-Dihydroxyphenylalanine
DL-Dioxyphenylalanine
|
DL-Β-(3,4-dihydroxyphenyl)alanine
DL-Β-(3,4-dihydroxyphenyl)-α-alanine
Dopa
Dopaflex
Dopaidan
Dopal
Dopal-Fher
Dopalina
Dopar
Doparkine
Doparl
Dopasol
Dopaston
Dopastone
Dopastral
Dopicar
Doprin
Eldopal
Eldopar
Eldopatec
Eurodopa
Helfo-dopa
INBRIJA
Insulamina
L 3,4 Dihydroxyphenylalanine
L Dopa
L-(-)-Dopa
L-3-(3,4-Dihydroxyphenyl)-alanine
L-3,4-Dihydroxyphenylalanine
L-4-5-Dihydroxyphenylalanine
Laradopa
Larodopa
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-b-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-Dihydroxyphenylalanine
L-DOPA
LDP540
Ledopa
Levedopa
Levodopa
Levodopum
Levopa
L-Β-(3,4-dihydroxyphenyl)alanine
Maipedopa
Medphano brand OF levodopa
NSC-118381
Parda
Pardopa
Prodopa
Roberts brand OF levodopa
Roche brand OF levodopa
SINEMET
Syndopa
V-1512
Veldopa
Weldopa
Β-(3,4-dihydroxyphenyl)alanine
Β-(3,4-dihydroxyphenyl)-DL-α-alanine
Β-(3,4-dihydroxyphenyl)-L-alanine
|
|
17 |
|
Dopamine |
Approved |
Phase 3 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
18 |
|
Cephalexin |
Approved, Investigational, Vet_approved |
Phase 3 |
|
15686-71-2 |
27447 |
Synonyms:
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
66873
7-(D-a-Aminophenylacetamido)desacetoxycephalosporanate
7-(D-a-Aminophenylacetamido)desacetoxycephalosporanic acid
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanate
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid
7-(D-Α-aminophenylacetamido)desacetoxycephalosporanate
7-(D-Α-aminophenylacetamido)desacetoxycephalosporanic acid
7-b-(D-a-Amino-a-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-b-(D-a-Amino-a-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
7-Β-(D-α-amino-α-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-Β-(D-α-amino-α-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
Anhydrous cefalexin
Anhydrous cephalexin
Cefalessina
Cefalexin
Cefalexin anhydrous
Cefalexina
Cefalexine
Céfalexine
Cefalexinum
Celexin
Cepastar
Cepexin
Cephacillin
CEPHALEXIN
Cephalexin 1-hydrate
Cephalexin anhydrous
|
Cephalexin dihydride
Cephalexin hemihydrate
Cephalexin hydrate
Cephalexin hydrochloride
Cephalexin monohydrate
Cephalexin monohydrochloride
Cephalexin monohydrochloride, monohydrate
Cephalexin, (6R-(6alpha,7alpha(r*)))-isomer
Cephalexin, (6R-(6alpha,7beta(s*)))-isomer
Cephalexin, (6R-(6alpha,7beta))-isomer
Cephalexin, monosodium salt
Cephalexin, monosodium salt, (6R-(6alpha,7beta))-isomer
Cephalexine
Cephalexinum
CEPOREX
Ceporexin
Ceporexine
CEX
Dihydride, cephalexin
Hemihydrate, cephalexin
Hydrochloride, cephalexin
KEFLET
Keflex
KEFTAB
Monohydrate cephalexin monohydrochloride
Monohydrate, cephalexin
Monohydrochloride, cephalexin
Monohydrochloride, monohydrate cephalexin
Monosodium salt cephalexin
Palitrex
|
|
19 |
|
Bacitracin |
Approved, Vet_approved |
Phase 3 |
|
1405-87-4 |
10909430 |
Synonyms:
A.L. labs brand OF bacitracin zinc salt
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
ALBAC 50
Altracin
Baci im
Baci RX
BACIFERM 50
BACIGUENT
Baci-im
BACIIM
Baci-RX
Bacitin
Bacitracin
Bacitracin a
Bacitracin a2a
Bacitracin akorn brand
Bacitracin dioptic brand
BACITRACIN F, 1-(N-((2-(1-AMINO-2-METHYLBUTYL)-4,5-DIHYDRO-4-THIAZOLYL)CARBONYL)-L-LEUCINE)-
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
|
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracina
Bacitracine martinet
Ciba vision brand OF bacitracin
Dioptic brand OF bacitracin
E700
Lee brand OF bacitracin
Martinet, bacitracine
McNeil brand OF bacitracin
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Reed and carnrick brand OF bacitracin
Topitracin
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
20 |
|
Levofloxacin |
Approved, Investigational |
Phase 3 |
|
100986-85-4 |
149096 |
Synonyms:
(-)-Ofloxacin
(2S)-7-FLUORO-2-METHYL-6-(4-METHYLPIPERAZIN-1-YL)-10-OXO-4-OXA-1-AZATRICYCLO[7.3.1.0^{5,13}]TRIDECA-5(13),6,8,11-TETRAENE-11-CARBOXYLIC ACID
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
Anhydrous, levofloxacin
Cravit
DR-3355
EVOXIL
FLOXACIN
Floxin
IQUIX
Levaquin
|
LEVOFLOXACIN
Levofloxacin anhydrous
LEVOFLOXACIN HEMIHYDRATE
Levofloxacin hydrate
Levofloxacine
Levofloxacino
Levofloxacinum
L-Ofloxacin
Ofloxacin
Ofloxacin S-(-)-form
OFLOXACIN S-(-)-FORM HEMIHYDRATE
Ofloxacin, (S)-isomer
OFTAQUIX
QUINSAIR
Quixin
RWJ-25213
TAVANIC
|
|
21 |
|
Polymyxin B |
Approved, Vet_approved |
Phase 3 |
|
1405-20-5, 1404-26-8 |
4868 |
Synonyms:
Aerosporin
Aerosporin®
N-[3-Amino-1-({1-[(3-amino-1-{[6,9,18-tris(2-aminoethyl)-15-benzyl-2,5,8,11,14,17,20-heptahydroxy-3-(1-hydroxyethyl)-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaen-21-yl]-C-hydroxycarbonimidoyl}propyl)-C-hydroxycarbonimidoyl]-2-hydroxypropyl}-C-hydroxycarbonimidoyl)propyl]-6-methyloctanimidate
Polimixina B
Polymixin b sulfate
Polymixin b sulphate
Polymyxin b
Polymyxin b sulfate
|
Polymyxin b sulfate salt
Polymyxin b sulfuric acid
Polymyxin b sulphate
Polymyxin b sulphate salt
Polymyxin b sulphuric acid
Polymyxine B
Polymyxinum B
Sulfate, polymyxin b
|
|
22 |
|
Ofloxacin |
Approved |
Phase 3 |
|
82419-36-1 |
4583 |
Synonyms:
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
Akilen
Baccidal
Bactocin
Danoflox
DL-8280
Effexin
EXOCIN
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
FLOXIN OTIC
Floxstat
Fugacin
Hoe 280
Hoe-280
Inoflox
J01MA01
Kinflocin
Kinoxacin
Liflox
Loxinter
Marfloxacin
Medofloxine
Mergexin
Novecin
Nufafloqo
Obide
Occidal
OCUFLOX
Ofcin
Oflin
Oflocee
Oflocet
|
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
OFLOXACIN
Ofloxacin hydrochloride
Ofloxacine
Ofloxacino
Ofloxacinum
Ofloxin
OFLX
Ofus
Onexacin
Operan
Orocin
Otonil
Pharflox
Praxin
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Sinflo
Tabrin
Taravid
Tariflox
Tarivid
TARIVID 400
TARIVID I.V.
Telbit
Tructum
Uro Tarivid
Viotisone
VISIREN
Zanocin
|
|
23 |
|
Clindamycin |
Approved, Vet_approved |
Phase 3 |
|
18323-44-9, 24729-96-2 |
29029 |
Synonyms:
7 Chloro 7 deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
ANTIROBE
Chlolincocin
Chlorlincocin
CHLORODEOXYLINCOMYCIN
CHLOROLINCOMYCIN
CLDM
Cleocin
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
CLEOCIN T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
CLINDAMYCIN
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
|
Clindamycin phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Evoclin
Hydrochloride, clindamycin
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
ResiDerm A
SOBELIN
U-21251
Zindaclin
|
|
24 |
|
Fludrocortisone |
Approved, Investigational |
Phase 3 |
|
127-31-1 |
31378 |
Synonyms:
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORANYL-10,13-DIMETHYL-11,17-BIS(OXIDANYL)-17-(2-OXIDANYLETHANOYL)-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-11,17-DIHYDROXY-17-(2-HYDROXY-1-OXOETHYL)-10,13-DIMETHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-11,17-DIHYDROXY-17-(2-HYDROXYACETYL)-10,13-DIMETHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-17-GLYCOLOYL-11,17-DIHYDROXY-10,13-DIMETHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
9 alpha Fludrohydrocortisone
9 alpha Fluoro 17 hydroxycorticosterone
9 alpha Fluorohydrocortisone
9 alpha-Fluoro-17-hydroxycorticosterone
9 alpha-Fluorohydrocortisone
9 Fluoro 17 hydroxycortisone
9 Fluorocortisol
9 Fluorohydrocortisone
9α-Flourocortisol|Florinef®
9a-FLUOROCORTISOL
9ALPHA-FLUOROCORTISOL
9-Fluoro-17-hydroxycortisone
9-Fluorocortisol
|
9-Fluorohydrocortisone
9Α-FLOUROCORTISOL
9Α-fluorocortisol
Astonin
Astonin H
Astonin merck
Astonin-H
FCOL
FLORINEF
FLUDROCORTISON
Fludrocortisona
FLUDROCORTISONE
Fludrocortisonum
FLUOHYDROCORTISONE
Merck brand OF fludrocortisone
Merck, astonin
|
|
25 |
|
Atomoxetine |
Approved |
Phase 3 |
|
82248-59-7, 83015-26-3 |
54841 |
Synonyms:
(-)-Tomoxetine
Atomoxetina
Atomoxetine
Atomoxetine HCL
Atomoxetine hydrochloride
HCL, Atomoxetine
Hydrochloride, atomoxetine
LY-139603
LY-139603|Strattera®
N-Methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride
Strattera
|
Tomoxetina
Tomoxetina [Spanish]
Tomoxetine
Tomoxetine [INN]
TOMOXETINE HCL
Tomoxetine hydrochloride, (-)-isomer
Tomoxetine hydrochloride, (+-)-isomer
Tomoxetine hydrochloride, (+)-isomer - T351671
Tomoxetinum
Tomoxetinum [Latin]
|
|
26 |
|
Antiparkinson Agents |
|
Phase 3 |
|
|
|
27 |
|
Dihydroxyphenylalanine |
|
Phase 3 |
|
|
|
28 |
|
Dopamine Agents |
|
Phase 3 |
|
|
|
29 |
|
Antipsychotic Agents |
|
Phase 3 |
|
|
|
30 |
|
Psychotropic Drugs |
|
Phase 3 |
|
|
|
31 |
|
Antidepressive Agents |
|
Phase 3 |
|
|
|
32 |
|
diuretics |
|
Phase 3 |
|
|
|
33 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
34 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
35 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
36 |
|
Polymyxins |
|
Phase 3 |
|
|
|
37 |
|
Anti-Infective Agents, Local |
|
Phase 3 |
|
|
|
38 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 3 |
|
|
|
39 |
|
Clindamycin phosphate |
|
Phase 3 |
|
|
32603 |
Synonyms:
Cleocin phosphate
Clindamycin phosphoric acid
Clindamycin-2-phosphate
|
|
|
40 |
|
Clindamycin palmitate |
|
Phase 3 |
|
|
|
41 |
|
Anti-Inflammatory Agents |
|
Phase 3 |
|
|
|
42 |
|
Norepinephrine |
Approved |
Phase 2 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
43 |
|
Acarbose |
Approved, Investigational |
Phase 2 |
|
56180-94-0 |
441184 444254 |
Synonyms:
Acarbosa
Acarbose
Acarbosum
Bay g 5421
Bayer brand OF acarbose
BAY-G 5421
BAY-G 5421|BAY-G-5421|Glucobay®|Precose®
|
BAY-G-5421
Glucobay
Glucor
Glumida
Lasa brand OF acarbose
Prandase
Precose
|
|
44 |
|
Caffeine |
Approved |
Phase 2 |
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
45 |
|
Capsaicin |
Approved |
Phase 2 |
|
404-86-4 |
1548943 |
Synonyms:
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
8 Methyl N vanillyl 6 nonenamide
8-Methyl-N-vanillyl-6-nonenamide
Alacan brand OF capsaicin
ALGRX 4975
ALGRX-4975
Antiphlogistine rub a-535 capsaicin
Axsain
CAPSAICIN
Capsaicina
Capsaicine
Capsicum farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Centrum brand OF capsaicin
e-Capsaicin
Elan brand OF capsaicin
epsilon-Capsaicin
FEMA NO. 3404
Flemming brand OF capsaicin
|
Gelcen
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Medicis brand OF capsaicin
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
NGX-1998
NGX-4010
NSC-56353
QUTENZA
Qutenza®
Smaller brand OF capsaicin
Styptysat
Thompson brand OF capsaicin
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
Vinas brand OF capsaicin
Zacin
Zostrix
ZOSTRIX HP
|
|
46 |
|
Droxidopa |
Approved, Investigational |
Phase 2 |
|
23651-95-8 |
443940 92974 |
Synonyms:
(-)-(2S,3R)-2-AMINO-3-HYDROXY-3-(3,4-DIHYDROXYPHENYL)PROPANOIC ACID
(2R,3S)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoate
(2S,3R)-3,4-DIHYDROXY-PHENYLSERINE
3,4 Dihydroxyphenylserine
3,4 Threo dops
3,4-Dihydroxyphenylserine
3,4-Threo-dops
DL Threo 3,4 dihydroxyphenylserine
DL-Threo-3,4-dihydroxyphenylserine
Dops
Droxidopa
Droxidopa, (DL-tyr)-isomer
Droxydopa
Erythro 3,4 dihydroxyphenylserine
|
Erythro-3,4-dihydroxyphenylserine
L-Dihydroxyphenylserine
L-DOPS
L-DOPS|Northera®|SM-5688
L-Threo-3,4-dihydroxyphenylserine
L-threo-dihydroxyphenylserine
L-THREODOPS
Northera
SM 5688
SM-5688
Threo dops
THREO-DOPASERINE
Threo-dops
|
|
47 |
|
Hypoglycemic Agents |
|
Phase 2 |
|
|
|
48 |
|
Cardiac Glycosides |
|
Phase 2 |
|
|
|
49 |
|
Glycoside Hydrolase Inhibitors |
|
Phase 2 |
|
|
|
50 |
|
Central Nervous System Stimulants |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 184)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Closed Loop Stimulation for Neuromediated Syncope |
Unknown status |
NCT01621464 |
Phase 4 |
|
2 |
A Randomized Clinical Trial of Fludrocortisone for Vasovagal Syncope: The Second Prevention of Syncope Trial (POST II) |
Completed |
NCT00118482 |
Phase 4 |
fludrocortisone acetate |
3 |
ISSUE3: International Study on Syncope of Uncertain Etiology 3 Pacemaker Therapy for Patients With Asystolic Neurally-mediated Syncope |
Completed |
NCT00359203 |
Phase 4 |
|
4 |
Propranolol for Syncope With Sympathoadrenal Imbalance |
Completed |
NCT00060866 |
Phase 4 |
Propranolol |
5 |
Early Loop-Recorder in Suspected Arrhythmogenic Syncope |
Completed |
NCT00170261 |
Phase 4 |
|
6 |
Syncope: Pacing or Recording in the Later Years (SPRITELY) |
Completed |
NCT01423994 |
Phase 4 |
|
7 |
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV (Post 4) |
Active, not recruiting |
NCT01456481 |
Phase 4 |
midodrine hydrochloride;matching placebo |
8 |
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects |
Active, not recruiting |
NCT02123056 |
Phase 4 |
Metoprolol;Matching Placebo |
9 |
Randomized Controlled Trial on Discontinuation of Vasoactive Drugs in Patients With Hypotensive Reflex Syncope |
Completed |
NCT02137278 |
Phase 3 |
Vasoactive drug therapies |
10 |
Randomized Noninferiority Study of an Antibacterial Envelope Alone Versus Envelope Plus Intraoperative Antibacterial Irrigant and Postoperative Antibiotics to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Patients |
Completed |
NCT02809131 |
Phase 3 |
polymixin/bacitracin;cephalexin, or levofloxacin, or clindamycin;Saline |
11 |
Comparison of Outcomes With Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS Trial) |
Recruiting |
NCT04595942 |
Phase 3 |
Midodrine Hydrochloride Tablets;Fludrocortisone Acetate Tablets |
12 |
A Randomized, Prospective, Placebo-Controlled, Crossover Study of Atomoxetine in the Prevention of Vasovagal Syncope (POST7) |
Recruiting |
NCT05159687 |
Phase 3 |
Atomoxetine Hydrochloride;Placebo |
13 |
Benefit of Controlled Rehydration in Unexplained Syncope |
Terminated |
NCT00143754 |
Phase 3 |
|
14 |
A Proof of Principle Study of Atomoxetine for the Prevention of Vasovagal Syncope (VVS): POST6 |
Completed |
NCT02500732 |
Phase 2 |
Atomoxetine;Placebo |
15 |
Preventing Adverse Reactions in Novice Blood Donors |
Completed |
NCT00302900 |
Phase 2 |
|
16 |
Non-Pharmacologic Therapy for Neurocardiogenic Syncope |
Completed |
NCT00096902 |
Phase 2 |
|
17 |
Propranolol for Syncope With Sympathoadrenal Imbalance in Children |
Completed |
NCT00093860 |
Phase 2 |
Propranolol |
18 |
Acarbose and Older Adults With Postprandial Hypotension |
Completed |
NCT01914133 |
Phase 2 |
Acarbose;Placebo |
19 |
The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope |
Recruiting |
NCT04972123 |
Phase 2 |
CPC - Capsaicin, Phenylephrine, Caffeine;Placebo |
20 |
Northera Improves Postural Tachycardia Syndrome (POTS) and Postural |
Active, not recruiting |
NCT02558972 |
Phase 2 |
Northera (Droxidopa);Placebo |
21 |
ELectrophysiological Mechanisms Underlying the Inhibitory CArdiac Syncope: Therapeutic and Prognostic Implications The ELICA Study |
Completed |
NCT02861274 |
Phase 1 |
|
22 |
Reducing Orthostatic Intolerance With Oral Rehydration in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
Active, not recruiting |
NCT02854683 |
Phase 1 |
Normal Saline |
23 |
EXercise for the Prevention of Syncope Evaluation |
Suspended |
NCT00203593 |
Phase 1 |
|
24 |
Optimizing Diagnostics And Therapy Of Arrhythmia And Syncope Events Using Intelligent Telemetric Solutions. Diagnostics Of Syncope In Children. |
Unknown status |
NCT01265290 |
|
|
25 |
Evaluation of a Mobile Cardiac Outpatient Telemetry System (CardioNet) Versus Standard Loop Event Monitor: A Multi-Center Randomized Study |
Unknown status |
NCT00295204 |
|
|
26 |
Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial |
Unknown status |
NCT00465946 |
|
|
27 |
Management of Sleep Apnoea Syndrome (SAS) in Patients With Vasovagal Syncope (VVS): a Protocol for the VVS-SAS Registry Study |
Unknown status |
NCT04294524 |
|
|
28 |
Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation |
Unknown status |
NCT03159156 |
|
|
29 |
The Iliac Arterio-venous Fistula for Treatment of Neurally Mediated Syncope Study |
Unknown status |
NCT02388087 |
|
|
30 |
Risk of Syncopal Relapses in Patients Treated With Permanent Pacing for Bradyarrhythmic Syncope |
Unknown status |
NCT04229589 |
|
|
31 |
Assessing the Risk of Pulmonary Embolism in Patients After Hospitalization for First Episode of Syncope |
Unknown status |
NCT03034525 |
|
|
32 |
Bradycardia High Risk Patient Identification After Syncope With Loop Recorder an Observational Study in Nancy University Hospital |
Unknown status |
NCT04200014 |
|
|
33 |
Eastbourne Syncope Assessment Study II |
Unknown status |
NCT00517023 |
|
|
34 |
Hypersensitive Troponin Performance to Identify Syncope at Risk of Serious Adverse Events in the Short Term |
Unknown status |
NCT03528161 |
|
|
35 |
OPTIMIZING DIAGNOSTICS AND THERAPY OF ARRHYTHMIA AND SYNCOPE EVENTS USING INTELLIGENT TELEMETRIC SOLUTIONS - Evaluation of Arrhythmia Treatment Efficacy |
Unknown status |
NCT01265303 |
|
|
36 |
Optimizing Diagnostics And Therapy Of Arrhythmia And Syncope Events Using Intelligent Telemetric Solutions. Diagnostics Of Arrhythmia In Children |
Unknown status |
NCT01265771 |
|
|
37 |
OPTIMIZING DIAGNOSTICS AND THERAPY OF ARRHYTHMIA AND SYNCOPE EVENTS USING INTELLIGENT TELEMETRIC SOLUTIONS - Evaluation of Arrhythmia Diagnostics in Adults |
Unknown status |
NCT01265758 |
|
|
38 |
Serum Lactate in Convulsive Syncopes Compared to Non-convulsive Syncopes |
Unknown status |
NCT03062683 |
|
|
39 |
EPIcardial and Endocardial Mapping and Ablation Using Contact Force Catheter in Chagasic Patients With Sustained Ventricular Tachycardia |
Unknown status |
NCT01847378 |
|
|
40 |
Registry Of Acute meDical Emergencies in Brazil - ROAD-Brazil |
Unknown status |
NCT02753023 |
|
|
41 |
Comparison of a Sternal ECG Patch With a Standard Recording System for Holter Monitoring |
Unknown status |
NCT02126631 |
|
|
42 |
REVEAL for Respiration Detection |
Unknown status |
NCT01956578 |
|
|
43 |
Observational Study of the Sleuth Implantable ECG Monitoring System |
Unknown status |
NCT00717106 |
|
|
44 |
Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial |
Unknown status |
NCT02031484 |
|
|
45 |
Evaluation of a New Cardiac Pacemaker |
Unknown status |
NCT01700244 |
|
|
46 |
Pilot Clinical Study of the Sleuth Implantable ECG Monitoring System |
Unknown status |
NCT00719277 |
|
|
47 |
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa |
Unknown status |
NCT03231449 |
|
|
48 |
NICE Guideline 'Red Flags' to Predict Serious Outcome After Transient Loss of Consciousness: Prospective Validation Study in the Emergency Department. |
Unknown status |
NCT01498471 |
|
|
49 |
CardioneuROablation for Reflex Syncope: Effects on autonoMic cArdiac Regulation and Efficacy Assessment - the Roman Syncope Study. |
Completed |
NCT03903744 |
|
|
50 |
Effect of Pacemaker With Closed Loop Sensor on Quality of Life and Recurrence of Syncope in Patients With Neuromodulated Syncope Refractory to Medical Treatment: Randomized Double-blind Clinical Trial |
Completed |
NCT03876652 |
|
|
|